Keybank National Association OH bought a new position in Cano Health, Inc. (NYSE:CANO – Get Rating) during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 30,000 shares of the company’s stock, valued at approximately $191,000.
Several other institutional investors have also made changes to their positions in the company. Samlyn Capital LLC boosted its holdings in shares of Cano Health by 328.8% during the fourth quarter. Samlyn Capital LLC now owns 4,988,187 shares of the company’s stock worth $44,444,000 after purchasing an additional 3,824,905 shares during the period. Owl Creek Asset Management L.P. boosted its holdings in shares of Cano Health by 29.2% during the fourth quarter. Owl Creek Asset Management L.P. now owns 4,869,804 shares of the company’s stock worth $43,390,000 after purchasing an additional 1,101,800 shares during the period. Capital World Investors boosted its holdings in shares of Cano Health by 12.3% during the fourth quarter. Capital World Investors now owns 9,596,818 shares of the company’s stock worth $85,508,000 after purchasing an additional 1,049,528 shares during the period. Transcend Capital Advisors LLC acquired a new stake in shares of Cano Health during the first quarter worth approximately $2,544,000. Finally, Swiss National Bank acquired a new stake in shares of Cano Health during the fourth quarter worth approximately $3,418,000. 37.64% of the stock is owned by hedge funds and other institutional investors.
Cano Health Stock Up 0.5 %
Shares of NYSE:CANO opened at $6.53 on Friday. Cano Health, Inc. has a 52 week low of $3.81 and a 52 week high of $15.58. The company has a debt-to-equity ratio of 1.10, a quick ratio of 2.04 and a current ratio of 2.04. The company’s fifty day moving average is $5.32 and its 200-day moving average is $5.67. The company has a market capitalization of $3.16 billion, a PE ratio of -23.32 and a beta of 1.24.
Analyst Ratings Changes
A number of research firms have issued reports on CANO. UBS Group reduced their target price on shares of Cano Health to $14.00 and set a “na” rating for the company in a research note on Tuesday, May 17th. Cowen reduced their target price on shares of Cano Health from $13.00 to $10.00 in a research note on Tuesday, May 10th. Piper Sandler reduced their price objective on shares of Cano Health from $5.00 to $4.00 in a research note on Tuesday, May 10th. Bank of America cut shares of Cano Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $8.00 to $6.00 in a research note on Wednesday, June 15th. Finally, Citigroup reduced their price objective on shares of Cano Health from $10.00 to $8.00 in a research note on Tuesday, May 10th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Cano Health presently has a consensus rating of “Moderate Buy” and an average target price of $10.90.
About Cano Health
Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.
- Get a free copy of the StockNews.com research report on Cano Health (CANO)
- Three Watchlist Stocks to Capitalize on Sector Rotation
- MarketBeat: Week in Review 7/18 – 7/22
- Falling Copper Prices Weigh On Freeport McMoran’s Earnings, But Long Term Fundamentals Intact
- Snap Stock Falters As Growth Slows To Record Low
- Lackluster Results Provide An Opportunity In Tractor Supply Company
Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.